Boston, MA -- (SBWIRE) -- 12/03/2013 -- GILUPI Nanomedizin (GILUPI) is a medical device company. The company develops and commercializes medical devices for isolating rare cells from blood for diagnosis. The company develops a new medical detector, which is used in-vivo in a patient's vein for catching rare cells such as tumor cells or fetal cells. GILUPI's products finds application in diagnosing lung cancer, breast cancer, prostate cancer and prenatal diagnosis. The company has developed CellCollector for the in vivo isolation of circulating tumor cells. Its patented process for the preparation of the medical device is based on the generation of a nanostructure on a medical stainless steel wire that is bound to antibodies. It has presence in Berlin, Hamburg, Cologne, Frankfurt and Munich. The company partners with Bayer Pharma AG, University Hospital Halle, Greater Poland Cancer Centre and University Medical Center Ulm, among others. GILUPI is headquartered in Postdam, Germany.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the GILUPI Nanomedizin portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Medtronic, Inc. (MDT) - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- SANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis, 2013 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update
- Cepheid (CPHD) - Product Pipeline Analysis, 2013 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2013 Update